PharmaBlock Sciences Nanjing Inc Class A (300725) — Cash Flow Quality Index
PharmaBlock Sciences Nanjing Inc Class A (300725) has a Cash Flow Quality Index of 2.04x as of September 2025. Operating cash flow of CN¥83.36 Million exceeds net income of CN¥40.89 Million, indicating high earnings quality where cash backs reported profits. Also explore 300725 total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PharmaBlock Sciences Nanjing Inc Class A Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for PharmaBlock Sciences Nanjing Inc Class A across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PharmaBlock Sciences Nanjing Inc Class A (300725) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for PharmaBlock Sciences Nanjing Inc Class A (2013–2024)
Year-by-year earnings quality comparison for PharmaBlock Sciences Nanjing Inc Class A. For live market cap and the full company financial profile, see 300725 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.38x | CN¥302.82 Million | CN¥219.54 Million | ▲ +10.3% |
| 2023 | 1.25x | CN¥246.84 Million | CN¥197.36 Million | ▲ +65.3% |
| 2022 | 0.76x | CN¥246.61 Million | CN¥325.89 Million | ▲ +60.2% |
| 2021 | 0.47x | CN¥238.03 Million | CN¥503.77 Million | ▼ -67.9% |
| 2020 | 1.47x | CN¥271.51 Million | CN¥184.20 Million | ▲ +76.4% |
| 2019 | 0.84x | CN¥127.04 Million | CN¥152.07 Million | ▼ -29.8% |
| 2018 | 1.19x | CN¥160.16 Million | CN¥134.50 Million | ▲ +47.7% |
| 2017 | 0.81x | CN¥54.64 Million | CN¥67.79 Million | ▲ +24.1% |
| 2016 | 0.65x | CN¥22.76 Million | CN¥35.04 Million | ▼ -53.1% |
| 2015 | 1.39x | CN¥27.52 Million | CN¥19.86 Million | ▲ +161.4% |
| 2014 | 0.53x | CN¥11.91 Million | CN¥22.46 Million | ▼ -47.2% |
| 2013 | 1.00x | CN¥18.32 Million | CN¥18.25 Million | — |